With the growing demand for early neurodegenerative disease detection, Cnpair provides immunoassay raw materials targeting key biomarkers associated with Alzheimer’s disease research and diagnostics. Our products support the development of next-generation detection platforms for neurological biomarker analysis, offering high specificity, sensitivity, and consistency for advanced immunoassay applications.